20 completed, 13 recruiting, 6 active not recruiting, 5 unknown. 14 Not applicable, 13 Phase 2, 7 Phase 3, 4 Phase 1.
Follow Colon Adenocarcinoma: new trials by email Literature Review of Colon Adenocarcinoma trials Research Report on Colon Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Probiotics on Neuropathy Induced by Adjuvant Chemotherapy in Patients With Colon Cancer. PROBIOTIC SUPPLEMENTATION BY OXXYSLAB®, PLACEBO supplementation - Colon Adenocarcinoma, Neuropathic Pain | Not applicable | Not yet recruiting | Centre Francois Baclesse | 130 | 2026-10-01 | 2026-07-30 |
| Improving Prognostication in Colon Cancer Blood draw for the laboratory assessment - Colon Cancer, Colon Adenocarcinoma | Not yet recruiting | Universitaire Ziekenhuizen KU Leuven | 400 | 2026-09-01 | 2026-06-29 | |
| Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma Longitudinal ctDNA-MRD NGS testing at scheduled postoperative time points - Colon Adenocarcinoma, Stage I Colon Cancer | Recruiting | Ruijin Hospital | 392 | 2026-08-14 | 2026-09-02 | |
| COLON ERDERLY LOW DOSE Colon Adenocarcinoma | Recruiting | Matteo Clavarezza | 51 | 2026-07-07 | 2026-07-16 | |
| Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma Tolecizumab (PCSK9 Inhibitor), Sintilimab - Colon Adenocarcinoma | Phase 2 | Recruiting | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 106 | 2026-04-10 | 2026-03-12 |
| Family Communications After Genetic Testing Biospecimen Collection, Genetic Testing, Communication Intervention - Colon Adenocarcinoma, Colorectal Adenocarcinoma | Not applicable | Recruiting | Alliance for Clinical Trials in Oncology | 4186 | 2026-04-06 | 2026-10-02 |
| Comparison of Laparoscopic and Open Total Mesocolic Excision With Central Vascular Ligation for Right Colon Carcinoma right hemicolectomy laparoscopic surgery, open rt hemicolectmy - Right-sided Colon Cancer, Colon Adenocarcinoma | Not applicable | Not yet recruiting | Kafrelsheikh University | 22 | 2026-01-01 | 2026-01-22 |
| A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) Calderasib, Oxaliplatin, Leucovorin/levofolinate calcium - Colon Adenocarcinoma, Rectal Adenocarcinoma | Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 477 | 2025-07-16 | 2026-10-07 |
| Current Microsatellite Stability Results in Colon Cancer Colon Adenocarcinoma, MSI Positive Colorectal Cancer | Not yet recruiting | Turkish Society of Colon and Rectal Surgery | 1500 | 2025-06-01 | 2025-05-14 | |
| Survival Outcomes by Tumor-Node Stage and Recurrence Patterns in Colon Cancer After Radical Surgery Colon Cancer, Colon Adenocarcinoma | Completed | Chang Gung Memorial Hospital | 7259 | 2025-04-09 | 2025-09-11 | |
| Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection blood sampling, Survey using a questionnaire. - Screening for Colon Cancer, Blood Samples | Not applicable | Recruiting | ADVANCED MARKER DISCOVERY S.L. | 4538 | 2025-01-14 | 2025-02-27 |
| Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma Organ-sparing surgery, Standard of care segmental resection - Colon Cancer, Colon Adenocarcinoma | Not applicable | Recruiting | Meander Medical Center | 341 | 2024-12-12 | 2025-11-20 |
| PeLear CCC: Proyecto Latino Contra Cancer Colorrectal Colorectal Cancer Educational Videos in Spanish - Colorectal Cancer, Rectal Cancer | Not applicable | Completed | University of North Carolina, Chapel Hill | 60 | 2024-10-27 | 2026-01-21 |
| HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer Chidamide + Tislelizumab + chemotherapy (CapeOX ), CapeOX - Colon Adenocarcinoma | Phase 2 | Recruiting | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 100 | 2024-10-15 | 2024-11-29 |
| Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. encorafenib + cetuximab + FOLFIRI - Colorectal Carcinoma, Colorectal Neoplasms | Phase 2 | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 25 | 2024-06-03 | 2025-02-12 |
| Optimization of Adaptive Text Messages for Cancer Survivors (OATS II) Dietary intervention via Text Messaging, Survey Administration, Nutrition Education - Colon Adenocarcinoma, Colorectal Carcinoma | Not applicable | Completed | University of California, San Francisco | 46 | 2023-11-03 | 2026-01-22 |
| Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer Encorafenib, Cetuximab, Biospecimen Collection - Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma | Phase 2 / Phase 3 | Active not recruiting | Alliance for Clinical Trials in Oncology | 1 | 2023-08-16 | 2026-07-02 |
| Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study Biospecimen Collection, Electronic Health Record Review, Fentanyl Citrate - Colon Adenocarcinoma | Phase 2 | Unknown | University of Kansas Medical Center | 80 | 2023-05-22 | 2023-08-30 |
| Evaluating Novel Therapies in ctDNA Positive GI Cancers Atezolizumab, Bevacizumab - Colon Adenocarcinoma, Rectal Adenocarcinoma | Phase 3 | Active not recruiting | Georgetown University | 11 | 2023-03-29 | 2026-10-06 |
| Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test Colorectal Cancer Screening, Colorectal Cancer Metastatic | Recruiting | Mainz Biomed | 2700 | 2022-12-18 | 2025-08-12 |
Showing 20 of 49. Sign in to see all of them.
Colonic Neoplasms (49) · Colorectal Neoplasms (17) · Rectal Neoplasms (16) · Colonic Polyps (2) · Colorectal Neoplasms, Hereditary Nonpolyposis (2) · Microsatellite Instability (2) · Neoplasm Metastasis (2) · Pancreatic Neoplasms (2) · Adenocarcinoma of Lung (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Colonic Diseases (1) · DNA Repair-Deficiency Disorders (1)
Digestive System Diseases (49) · Digestive System Neoplasms (49) · Gastrointestinal Diseases (49) · Gastrointestinal Neoplasms (49) · Intestinal Diseases (49) · Intestinal Neoplasms (49) · Neoplasms by Site (49) · Colonic Diseases (48) · Neoplasms (48) · Colorectal Neoplasms (32) · Rectal Diseases (26) · Pathological Conditions, Signs and Symptoms (7) · Adenocarcinoma (3) · Carcinoma (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)
Oxaliplatin (8) · Fluorouracil (6) · Leucovorin (5) · dehydroftorafur (5) · Bevacizumab (4) · Cetuximab (4) · Capecitabine (3) · Irinotecan (3) · Watchful Waiting (3) · Blood Specimen Collection (2) · Disulfides (2) · Immunoglobulin G (2) · Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · atezolizumab (2)
National Cancer Institute (NCI) (3) · Alliance for Clinical Trials in Oncology (2) · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (2) · M.D. Anderson Cancer Center (2) · Roswell Park Cancer Institute (2) · ADVANCED MARKER DISCOVERY S.L. (1) · Academic and Community Cancer Research United (1) · Azienda Ospedaliero-Universitaria di Modena (1) · CENTOGENE GmbH Rostock (1) · Centre Francois Baclesse (1) · Chang Gung Memorial Hospital (1) · D'Or Institute for Research and Education (1) · Dana-Farber Cancer Institute (1) · Edward Kim (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)
United States (23) · France (6) · Italy (5) · Puerto Rico (5) · China (4) · Canada (3) · Germany (3) · Spain (3) · Brazil (2) · Israel (2) · Netherlands (2) · South Korea (2) · Taiwan (2) · Turkey (Türkiye) (2) · United Kingdom (2)
Frank A Sinicrope (2) · Agustin Albillos, MD (1) · Al B Benson (1) · Alexis Leal, MD (1) · Ana Rita, MD (1) · Anass M Majbar (1) · Burak Yavuz, M.D. (1) · Carmen J Allegra (1) · Christos Fountzilas (1) · Cihangir Akyol, Professor (1) · Edward Kim (1) · Erin Van Blarigan, ScD (1) · Farshid Dayyani, MD, PhD (1)
PMID 10493478, PMID 11167863, PMID 11171826, PMID 17103254, PMID 18245012, PMID 1989293, PMID 20060381, PMID 21042942, PMID 21751045, PMID 21997132, PMID 23152705, PMID 23233715, PMID 23432814, PMID 23494765, PMID 24028813, PMID 24370906, PMID 24840647, PMID 25057166, PMID 25195558, PMID 25572686, PMID 25692361, PMID 26774139, PMID 26866579, PMID 27108243, PMID 27986363, PMID 28006055, PMID 28513862, PMID 28544246, PMID 28596308, PMID 28712102, PMID 28930294, PMID 29026950, PMID 29168565, PMID 29532908, PMID 29727331, PMID 29916882, PMID 30787022, PMID 30871626, PMID 31188200, PMID 31262657, PMID 31268130, PMID 31520204, PMID 31674105, PMID 31811950, PMID 32305529, PMID 32391971, PMID 32653824, PMID 32702383, PMID 32792859, PMID 33109741
P30CA016056 (2), 2023 (1), P30CA015083 (1), P30CA046934 (1), P30CA093373 (1), P30CA168524 (1), R21CA263539 (1), U10CA012027 (1), U10CA021115 (1), U10CA180820 (1), U10CA180821 (1), U10CA180868 (1), U10CA180888 (1)